RecruitingNot ApplicableNCT06835829

Comparing Advanced Hemostasis and Ultrasound-Guided Puncture to Conventional Approaches in Distal Radial Access

Comparing Advanced Hemostasis and Ultrasound-Guided Puncture to Conventional Approaches in Distal Radial Access: A Dual Randomized Pragmatic Trial


Sponsor

Associazione per lo Studio delle Malattie Cardiovascolari Cardiva ONLUS

Enrollment

480 participants

Start Date

Dec 31, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Meta-analysis results show that distal radial access (DRA) is associated with a significant reduction in the risk of radial artery occlusion compared to conventional transradial access (TRA). This is of paramount importance in an evolving interventional context where an increasing number of radial access procedures are being performed to address a growing number of independent health conditions. DRA is also associated with a lower rate of vascular access-related adverse events, establishing it as the safest vascular access ever. However, available data show that the success rate of DRA is lower than that of conventional TRA. Also, while the duration of hemostasis has been shown to be shorter, it has most likely not yet reached its full potential for shortening. Thus, the two extreme phases of DRA require important further evaluation. The CompAring uLtrasound-guided Puncture and advanced HemostAsis to cOnventional approaches in distal radial access: a dual randoMizEd praGmatic triAl (ALPHA\&OMEGA) trial will address this lack of knowledge by exploring whether a significantly shorter hemostasis duration can be achieved with DRA when using hemostasis enhancement and exploring whether ultrasound-guided puncture can increase the success rate of DRA.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Conventional guidance, a medical device called Distal radial potassium ferrate hemostatic patch, and others for people with coronary catheterization. The study is currently recruiting participants at 6 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICETransradial potassium ferrate hemostatic patch

Use of a potassium ferrate hemostatic patch to enhance transradial access hemostasis

DEVICEDistal radial potassium ferrate hemostatic patch

Use of a potassium ferrate hemostatic patch to enhance distal radial access hemostasis

PROCEDUREUltrasound-guidance

Ultrasound guidance for distal radial access

PROCEDUREConventional guidance

Conventional guidance for distal radial access


Locations(6)

Groupe Vivalia, Clinique Saint-Joseph

Arlon, Belgium

CHU Charleroi-Chimay, Marie Curie Hospital

Charleroi, Belgium

CHU Helora, Jolimont Hospital

La Louvière, Belgium

Sant'Eugenio Hospital

Roma, RM, Italy

Sandro Pertini Hospital

Roma, RM, Italy

Mater Salutis Hospital

Legnago, VR, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06835829


Related Trials